Skip to content
← Holders

Gilead Sciences, Inc.

What Gilead Sciences, Inc. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 882095 · Filed Nov 6, 2026

Positions
5
Reported value
$1.5B
Opened
0
Closed
0
Other managers included
1

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$1.8B
    9 positions
  2. Dec 31, 2025$1.9B
    6 positions
  3. Mar 31, 2026$2.1B
    6 positions
  4. Jun 30, 2026$1.6B
    5 positions
  5. Sep 30, 2026$1.5B
    5 positions
SecuritySharesChangeValueOf portfolio
RCUSArcus Biosciences, Inc.
31.4M±0%$811.7M55.5%
LKFTLakefront Biotherapeutics NV
16.7M±0%$501.3M34.2%
ASMBAssembly Biosciences, Inc.
5M±0%$116.9M8%
KYTXKyverna Therapeutics, Inc.
4.1M±0%$28.1M1.9%
XLOXilio Therapeutics, Inc.
650.4K±0%$5.9M0.4%